Macrocyclic lactones in the treatment and control of parasitism in small companion animals

Current Pharmaceutical Biotechnology

Volumn 13, Issue 6, 2012, Pages 1078-1094

  Nolan, Thomas J ^a   Lok, James B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cat; Dirofilaria; Dog; Exotics; Ivermectin; Milbemycin; Moxidectin; Parasite; Selamectin

Indexed keywords

ACAREXX; ADVANTAGE DUO; ADVANTAGE MULTI; ADVOCATE; ANTIPARASITIC AGENT; FENBENDAZOLE; GUARDIAN; HEARTGARD; INTERCEPTOR; IVERHART; IVERMECTIN; MILBEMITE; MILBEMYCIN; MILBEMYCIN OXIME; MOXIDECTIN; PRO HEART 6; PROHEART; SELAMECTIN; SENTINEL; STRONGHOLD; TRI HEART PLUS; UNCLASSIFIED DRUG;

ACANTHOCHEILONEMA RECONDITUM; ANCYLOSTOMA; ANCYLOSTOMIASIS; ARTICLE; CATABOLISM; DIROFILARIA IMMITIS; DIROFILARIA REPENS; DIROFILARIASIS; DOG; DRUG FORMULATION; DRUG RELEASE; FLEA; FLEA BITE; IXODIDAE; NONHUMAN; PARASITISM; SPIROCERCA LUPI; THELAZIA; TICK; TICK BITE; TOXASCARIASIS; TOXASCARIS LEONINA;

ACANTHOCHEILONEMA RECONDITUM; ACARI; ANCYLOSTOMA; ANCYLOSTOMATOIDEA; ANIMALIA; CANIS FAMILIARIS; CAPILLARIA; DERMANYSSIDAE; DIROFILARIA; DIROFILARIA IMMITIS; DIROFILARIA REPENS; IXODIDA; NEMATODA; OTODECTES CYNOTIS; SARCOPTIFORMES; SIPHONAPTERA (FLEAS); SPIROCERCA LUPI; THELAZIA; TOXASCARIS LEONINA; TOXOCARA; TROMBICULIDAE;

EID: 84860521789     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800399167     Document Type: Article

References (187)

1. Humbert-Droz, E.; Buscher, G.; Cavalleri, D.; Junquera, P. Efficacy of milbemycin oxime against fourth-stage larvae and adults of Ancylostoma tubaeforme in experimentally infected cats. Vet. Rec., 2004, 154(5), 140-143.
2. Traversa, D.; Di Cesare, A.; Milillo, P.; Lohr, B.; Iorio, R.; Pampurini, F.; Schaper, R.; Paoletti, B.; Heine, J. Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline aelurostrongylosis. Parasitol. Res., 2009, 105(Suppl. 1), S55-62.
3. Tarello, W. Identification and treatment of Dipetalonema grassii microfilariae in a cat from central Italy. Vet. Rec., 2004, 155(18), 565-566.
4. Kirkpatrick, C.E.; Megella, C. Use of ivermectin in treatment of Aelurostrongylus abstrusus and Toxocara cati infection in a cat. J. Am. Vet. Med. Assoc., 1987, 190(10), 1309-1310.
5. Kirkpatrick, C.E.; Nelson, G.R. Ivermectin treatment of urinary capillariasis in a dog. J. Am. Vet. Med. Assoc., 1987, 191(6), 701-702.
6. Paradis, M.; Scott, D.; Villeneuve, A. Efficacy of ivermectin against Cheyletiella blakei infestation in cats. J. Am. Anim. Hosp. Assoc., 1990, 26(2), 125-128.
7. Itoh, N.; Muraoka, N.; Aoki, M.; Itagaki, T. Treatment of Notoedres cati infestation in cats with selamectin. Vet. Rec., 2004, 154(13), 409.
8. Beck, W.; Pantchev, N. Sarcoptes scabiei infestation (Acari: Sarcoptidae) in the cat-a case report and an overview. Prakt. Tierarzt, 2009, 90(8), 712-719.
9. Yazwinski, T.A.; Pote, L.; Tilley, W.; Rodriguez, C.; Greenway, T. Efficacy of ivermectin against Sarcoptes scabiei and Otodectes cynotis infestations of dogs. Vet. Clin. N. Am. Small Anim. Pract., 1981, 76(12), 1749-1751.
10. Scheidt, V.J.; Medleau, L.; Seward, R.L.; Schwartzman, R.M. An evaluation of ivermectin in the treatment of sarcoptic mange in dogs. Am. J. Vet. Res., 1984, 45(6), 1201-1202.
11. Shoop, W.; Soll, M. In: Macrocyclic lactones in antiparasitic therapy, J. Vercruysse; R. S. Rew, Eds.; CAB International: Wallingford, UK, 2002, pp. 1-29.
12. Schenker, R.; Cody, R.; Strehlau, G.; Junquera, P. Repeat dose tolerance of a combination of milbemycin oxime and praziquantel in breeding and lactating queens. Int. J. Appl. Res. Vet. Med., 2005, 3(4), 360-366.
13. Krautmann, M.J.; Novotny, M.J.; De Keulenaer, K.; Godin, C.S.; Evans, E.I.; McCall, J.W.; Wang, C.; Rowan, T.G.; Jernigan, A.D. Safety of selamectin in cats. Vet. Parasitol., 2000, 91(3-4), 393-403.
14. Epe, C.; Roesler, K.; Schnieder, T. Investigations into the prevention of neonatal Ancylostoma caninum infections in puppies by application of moxidectin to the bitch. J. Vet. Med. Series B, 1999, 46(6), 361-367.
15. Campbell, W.C.; Blair, L.S. Efficacy of avermectins against Dirofilaria immitis in dogs. J. Helminthol., 1978, 52(4), 308-10.
16. Blair, L.S.; Campbell, W.C. Trial of avermectin B1a, mebendazole and melarsoprol against pre-cardiac Dirofilaria immitis in the ferret (Mustela putorius furo). J. Parasitol., 1978, 64(6), 1032-4.
17. Kotani, T.; Powers, K.G. Developmental stages of Dirofilaria immitis in the dog. Am. J. Vet. Res., 1982, 43(12), 2199-206.
18. McCall, J.W.; Lindemann, B.A.; Porter, C.A. In: Proceedings of the Heartworm Symposium '80, G. F. Otto, Ed.; Veterinary Medicine Publishing Co.: Edwardsville, KS, 1981, pp. 126-130.
19. Sutton, R.H. In: Dirofilariasis, R. B. Atwell; P. F. L. Boreham, Eds.; CRC Press, Inc.: Boca Raton, Florida, 1988, pp. 99-132.
20. Genchi, C.; Venco, L.; Ferrari, N.; Mortarino, M.; Genchi, M. Feline heartworm (Dirofilaria immitis) infection: A statistical elaboration of the duration of the infection and life expectancy in asymptomatic cats. Vet. Parasitol., 2008, 158(3), 177-182.
21. Dillon, A.R.; Blagburn, B.L.; Tillson, D.M.; Brawner, W.R.; Welles, B.; Johnson, C.; Spenser, J.; Kaltenboeck, B.; Rynders, P.E. Immature heartworm infection produces pulmonary parenchymal, airway, and vascular disease in cats. J. Vet. Intern. Med., 2007, 21(3), 608-609 (Abstract 133).
22. Gates, M.C.; Nolan, T.J. Factors influencing heartworm, flea, and tick preventative use in patients presenting to a veterinary teaching hospital. Prev. Vet. Med., 2010, 93(2-3), 193-200.
23. McCall, J.W.; Dzimianski, M.T.; Plue, R.E.; Seward, H.L.; Blair, L.S. In: Proceedings of the Heartworm Symposium '86, G. F. Otto, Ed.; American Heartworm Society: Washington, 1986, pp. 9-13.
24. Grieve, R.B.; Frank, G.R.; Stewart, V.A.; Parsons, J.C.; Belasco, D.L.; Hepler, D.I. Chemoprophylactic effects of milbemycin oxime against larvae of Dirofilaria immitis during prepatent development. Am. J. Vet. Res., 1991, 52(12), 2040-2042.
25. McTier, T.L.; Shanks, D.J.; Watson, P.; McCall, J.W.; Genchi, C.; Six, R.H.; Thomas, C.A.; Dickin, S.K.; Pengo, G.; Rowan, T.G.; Jernigan, A.D. Prevention of experimentally induced heartworm (Dirofilaria immitis) infections in dogs and cats with a single topical application of selamectin. Vet. Parasitol., 2000, 91(3-4), 259-268.
26. McCall, J.W. The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations. Vet. Parasitol., 2005, 133(2-3), 197-206.
27. McCall, J.W.; Genchi, C.; Kramer, L.H.; Guerrero, J.; Venco, L. Heartworm disease in animals and humans. Adv. Parasitol., 2008, 66, 193-285.
28. McCall, J.W. The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations. Vet. Parasitol., 2005, 133(2-3), 197-206.
29. McCall, J.W.; McTier, T.L.; Supakordej, N.; Ricketts, R. In: Proceedings of the Heartworm Symposium '95, D. H. Knight, Ed.; American Heartworm Society: Batavia, IL, 1995, pp. 187-195.
30. Williams, J.C.; Loyacano, A.F.; DeRosa, A.; Gurie, J.; Clymer, B.C.; Guerino, F. A comparison of persistent anthelmintic efficacy of topical formulations of doramectin, ivermectin, eprinomectin and moxidectin against naturally acquired nematode infections of beef calves. Vet. Parasitol, 1999, 85(4), 277-88.
31. McTier, T.L.; Shanks, D.J.; Watson, P.; McCall, J.W.; Genchi, C.; Six, R.H.; Thomas, C.A.; Dickin, S.K.; Pengo, G.; Rowan, T.G.; Jernigan, A.D. Prevention of experimentally induced heartworm (Dirofilaria immitis) infections in dogs and cats with a single topical application of selamectin. Vet. Parasitol., 2000, 91(3-4), 259-68.
32. Boy, M.G.; Six, R.H.; Thomas, C.A.; Novotny, M.J.; Smothers, C.D.; Rowan, T.G.; Jernigan, A.D. Efficacy and safety of selamectin against fleas and heartworms in dogs and cats presented as veterinary patients in North America. Vet. Parasitol., 2000, 91(3-4), 233-50.
33. Bishop, B.F.; Bruce, C.I.; Evans, N.A.; Goudie, A.C.; Gration, K.A.; Gibson, S.P.; Pacey, M.S.; Perry, D.A.; Walshe, N.D.; Witty, M.J. Selamectin: a novel broad-spectrum endectocide for dogs and cats. Vet. Parasitol., 2000, 91(3-4), 163-176.
34. Arther, R.G.; Bowman, D.D.; Slone, R.L.; Travis, L.E. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs. Parasitol. Res., 2005, 97 (Suppl 1), S76-80.
35. Arther, R.G.; Bowmann, D.D.; McCall, J.W.; Hansen, O.; Young, D.R. Feline Advantage Heart (imidacloprid and moxidectin) topical solution as monthly treatment for prevention of heartworm infection (Dirofilaria immitis) and control of fleas (Ctenocephalides felis) on cats. Parasitol. Res., 2003, 90 (Suppl 3), S137-139.
36. Arther, R.G.; Charles, S.; Ciszewski, D.K.; Davis, W.L.; Settje, T.S. Imidacloprid/moxidectin topical solution for the prevention of heartworm disease and the treatment and control of flea and intestinal nematodes of cats. Vet. Parasitol., 2005, 133(2-3), 219-225.
37. Krautmann, M.J.; Novotny, M.J.; De Keulenaer, K.; Godin, C.S.; Evans, E.I.; McCall, J.W.; Wang, C.; Rowan, T.G.; Jernigan, A.D. Safety of selamectin in cats. Vet. Parasitol., 2000, 91(3-4), 393-403.
38. Novotny, M.J.; Krautmann, M.J.; Ehrhart, J.C.; Godin, C.S.; Evans, E.I.; McCall, J.W.; Sun, F.; Rowan, T.G.; Jernigan, A.D. Safety of selamectin in dogs. Vet. Parasitol., 2000, 91(3-4), 377-391.
39. Arther, R.G.; Atkins, C.; Ciszewski, D.K.; Davis, W.L.; Ensley, S.M.; Settje, T.L. Safety of imidacloprid plus moxidectin topical solution applied to cats heavily infected with adult heartworms (Dirofilaria immitis). Parasitol. Res., 2005, 97 (Suppl 1), S70-75.
40. Paul, A.J.; Hutchens, D.E.; Firkins, L.D.; Borgstrom, M. Dermal safety study with imidacloprid/moxidectin topical solution in the ivermectin-sensitive collie. Vet. Parasitol., 2004, 121(3-4), 285-291.
41. Venco, L.; Mortarino, M.; Carro, C.; Genchi, M.; Pampurini, F.; Genchi, C. Field efficacy and safety of a combination of moxidectin and imidacloprid for the prevention of feline heartworm (Dirofilaria immitis) infection. Vet. Parasitol., 2008, 154(1-2), 67-70.
42. Hong, C.; Harris, T.J.; Grimshaw, W.T.; Newcomb, K.M. Persistent activity of ivermectin topical and moxidectin injection against Ostertagia ostertagi and Dictyocaulus viviparus in calves. Vet. Rec, 1995, 137(25), 640-641.
43. Dorny, P.; Demeulenaere, D.; Smets, K.; Claerebout, E.; Vercruysse, J. Persistent efficacy of topical doramectin and eprinomectin against Ostertagia ostertagi and Cooperia oncophora infections in cattle. Vet. Rec., 2000, 147(5), 139-140.
44. Cramer, L.G.; Pitt, S.R.; Rehbein, S.; Gogolewski, R.P.; Kunkle, B.N.; Langhoff, W.K.; Bond, K.G.; Maciel, A.E. Persistent efficacy of topical eprinomectin against nematode parasites in cattle. Parasitol. Res., 2000, 86(11), 944-946.
45. Heaney, K.; Lindahl, R.G. Safety evaluation of moxidectin sustained-release injectable in 10-week-old puppies. Vet. Parasitol., 2005, 133(2-3), 227-231.
46. Lok, J.B.; Knight, D.H.; Wang, G.T.; Doscher, M.E.; Nolan, T.J.; Hendrick, M.J.; Steber, W.; Heaney, K. Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis. Am. J. Vet. Res., 2001, 62(11), 1721-1726.
47. Genchi, C.; Rossi, L.; Cardini, G.; Kramer, L.H.; Venco, L.; Casiraghi, M.; Genchi, M.; Agostini, A. Full season efficacy of moxidectin microsphere sustained release formulation for the prevention of heartworm (Dirofilaria immitis) infection in dogs. Vet. Parasitol., 2002, 110(1-2), 85-91.
48. Holm-Martin, M.; Atwell, R. Evaluation of a single injection of a sustained-release formulation of moxidectin for prevention of experimental heartworm infection after 12 months in dogs. Am. J. Vet. Res., 2004, 65(11), 1596-1599.
49. Lok, J.B.; Knight, D.H.; Nolan, T.J.; Grubbs, S.T.; Cleale, R.M.; Heaney, K. Efficacy of an injectable, sustained-release formulation of moxidectin in preventing experimental heartworm infection in mongrel dogs challenged 12 months after administration. Vet. Parasitol., 2005, 128(1-2), 129-135.
50. Lok, J.B.; Washabau, R.J.; Heaney, K.; Nolan, T.J.; Hendrick, M.J.; Neumann, N.R.; Ulrich, M. Six-month prophylactic efficacy of moxidectin sustained release (SR) injectable for dogs against experimental heartworm infection in growing puppies. Vet. Parasitol., 2005, 133(2-3), 233-241.
51. Clark, S.L.; Crowley, A.J.; Schmidt, P.G.; Donoghue, A.R.; Piche, C.A. Long-term delivery of ivermectin by use of poly(D, L-lacticco-glycolic)acid microparticles in dogs. Am. J. Vet. Res., 2004, 65(6), 752-757.
52. Lok, J.B.; Knight, D.H.; McCall, J.W.; Dzimianski, M.T.; Cleale, R.M.; Wang, G.T.; Doscher, M.E.; Nolan, T.J.; Hendrick, M.J.; Steber, W.; Heaney, K. In: Recent Advances in Heartworm Disease-Symposium '01, H. L. Seward, Ed.; The American Heartworm Society: Batavia, Ill, 2002, pp. 149-157.
53. Kuehn, B.M. Fort Dodge recalls ProHeart 6, citing FDA safety concerns. Advisory committee to review FDA findings. J. Am. Vet. Med. Assoc., 2004, 225(8), 1157-1158.
54. Glickman, L.T.; Glickman, N.W.; Moore, G.E.; Cobb, R.; Connell, S.A.; Morrison, M.; Lewis, H. Safety profile of moxidectin (Proheart 6) and two oral heartworm preventatives in dogs. Int. J. Appl. Res. Vet. Med., 2005, 3(2), 49-61.
55. McCall, J.W.; McTier, T.L.; Holmes, R.A.; Greene, T.; Strickland, J.; Aguilar, R. In: Proceedings of the Heartworm Symposium '92, M. D. Soll, Ed.; American Heartworm Society: Batavia, IL, 1992, pp. 169-177.
56. McCall, J.W.; Guerrero, J.; Roberts, R.E.; Supakorndej, N.; Mansour, A.E.; Dzimianski, M.T.; McCall, S.D. In: Recent Advances in Heartworm Disease: Symposium '01., R. L. Seward, Ed.; American Heartworm Society: Batavia, IL, 2001, pp. 189-200.
57. Venco, L.; McCall, J.W.; Guerrero, J.; Genchi, C. Efficacy of longterm monthly administration of ivermectin on the progress of naturally acquired heartworm infections in dogs. Vet. Parasitol., 2004, 124(3-4), 259-268.
58. Bazzocchi, C.; Mortarino, M.; Grandi, G.; Kramer, L.H.; Genchi, C.; Bandi, C.; Genchi, M.; Sacchi, L.; McCall, J.W. Combined ivermectin and doxycycline treatment has microfilaricidal and adulticidal activity against Dirofilaria immitis in experimentally infected dogs. Int. J. Parasitol., 2008, 38(12), 1401-1410.
59. Grandi, G.; Quintavalla, C.; Mavropoulou, A.; Genchi, M.; Gnudi, G.; Bertoni, G.; Kramer, L. A combination of doxycycline and ivermectin is adulticidal in dogs with naturally acquired heartworm disease (Dirofilaria immitis). Vet. Parasitol., 2010, 169(3-4), 347-3451.
60. Nelson, C.T.; McCall, J.W.; Rubin, S.B.; Buzhardt, L.F.; Dorion, D.W.; Graham, W.; Longhofer, S.L.; Guerrero, J.; Robertson-Plouch, C.; Paul, A. 2005 Guidelines for the diagnosis, prevention and management of heartworm (Dirofilaria immitis) infection in cats. Vet. Parasitol., 2005, 133(2-3), 267-275.
61. Blagburn, B.L.; Hendrix, C.M.; Lindsay, D.S.; Vaughan, B.S.; Hepler, D.I. In: Proceedings of the Heartworm Symposium '92, M. D. Soll, Ed.; American Heartworm Society: Batavia IL, 1999, pp. 159-164.
62. Hamilton, R.G.; Wagner, E.; April, M.; Winkelstein, J.A.; Sobotka, A.K.; Bleeker, E.; Adkinson, N.F., Jr. Dirofilaria immitis: diethylcarbamazine-induced anaphylactoid reactions in infected dogs. Exp. Parasitol., 1986, 61(3), 405-420.
63. Waller, P.J. Anthelmintic resistance. Vet. Parasitol., 1997, 72(3-4), 391-405; discussion 405-412.
64. Prichard, R.K. Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs? Vet. Parasitol., 2005, 133(2-3), 243-253.
65. Bowman, D.D.; Johnson, R.C.; Ulrich, M.E.; Neumann, N.R.; Lok, J.B.; Zhang, Y.; Knight, D.H. In: Proceedings of the Heartworm Symposium '92, M. D. Soll, Ed.; American Heartworm Society: Batavia IL, 1992, pp. 151-158.
66. Bowman, D.D.; Neumann, N.R.; Rawlings, C.; Stansfield, D.G.; Legg, W. In: Recent Advances in Heartworm Disease: Symposium '01., R. L. Seward, Ed.; American Heartworm Society: Batavia, IL, 2001, pp. 173-178.
67. Egerton, J.R.; Eary, C.H.; Suhayda, D. Dose-titration studies of ivermectin against experimental Ancylostoma caninum and Uncinaria stenocephala infections. Am. J. Vet. Res., 1985, 46(5), 1057-1059.
68. Yazwinski, T.A.; Hamm, D.; Williams, M.; Greenway, T.; Tilley, W. Effectiveness of ivermectin in the treatment of equine Parascaris equorum and Oxyuris equi infections. Am. J. Vet. Res., 1982, 43(6), 1095.
69. Anderson, D.L.; Roberson, E.L. Activity of ivermectin against canine intestinal helminths. Am. J. Vet. Res., 1982, 43(9), 1681-1683.
70. Campbell, W.C.; Benz, G.W. Ivermectin: a review of efficacy and safety. J. Vet. Pharmacol. Ther., 1984, 7(1), 1-16.
71. Mansfield, L.S.; Schad, G.A. Ivermectin treatment of naturally acquired and experimentally induced Strongyloides stercoralis infections in dogs. J. Am. Vet. Med. Assoc., 1992, 201(5), 726-730.
72. Lin, S.; Wang, W.; Yang, C.; Liu, P.; Tung, K. Treatment effects of ivermectin, levamisole, and Advantix (R) for Thelazia callipaeda in dogs. Taiwan Vet. J., 2008, 34(4), 233-238.
73. Mylonakis, M.E.; Rallis, T.S.; Koutinas, A.F.; Ververidis, H.N.; Fytianou, A. A comparison between ethanol-induced chemical ablation and ivermectin plus prednizolone in the treatment of symptomatic esophageal spirocercosis in the dog: a prospective study on 14 natural cases. Vet. Parasitol., 2004, 120(1-2), 131-138.
74. Boersema, J.H.; Baas, J.J.M.; Schaeffer, F. Persistent kennel cough caused by Filaroides osleri in a dog. Tijdschr. Diergeneeskd., 1989, 114(1), 10-13.
75. Outerbridge, C.A.; Taylor, S.M. Oslerus osleri tracheobronchitis: treatment with ivermectin in 4 dogs. Can. Vet. J., 1998, 39(4), 238-240.
76. Cagnasso, A.; Peirone, B. Dermatitis due to Pelodera strongyloides in a dog. Summa, 1988, 5(1), 74.
77. Evinger, J.V.; Kazacos, K.R.; Cantwell, H.D. Ivermectin for treatment of nasal capillariasis in a dog. J. Am. Vet. Med. Assoc., 1985, 186(2), 174-175.
78. Lindemann, B.A.; McCall, J.W. Microfilaricidal activity of ivermectin against Dipetalonema reconditum. J. Vet. Pharmacol. Ther., 1983, 6(1), 75-76.
79. McTier, T.L.; Siedek, E.M.; Clemence, R.G.; Wren, J.A.; Bowman, D.D.; Hellmann, K.; Holbert, M.S.; Murphy, M.G.; Young, D.R.; Cruthers, L.R.; Smith, D.G.; Shanks, D.J.; Rowan, T.G.; Jernigan, A.D. Efficacy of selamectin against experimentally induced and naturally acquired ascarid (Toxocara canis and Toxascaris leonina) infections in dogs. Vet. Parasitol., 2000, 91(3-4), 333-345.
80. Kelly, P.J.; Fisher, M.; Lucas, H.; Krecek, R.C. Treatment of esophageal spirocercosis with milbemycin oxime. Vet. Parasitol., 2008, 156, 358-360.
81. Conboy, G. Natureal infections of Crenosoma vulpis and Angiostrongylus vasorum in dogs in Atlantic Canada and their treatment with milbemycin oxime. Vet. Rec., 2004, 155(1), 16-18.
82. Ferroglio, E.; Rossi, L.; Tomio, E.; Schenker, R.; Bianciardi, P. Therapeutic and prophylactic efficacy of milbemycin oxime (Interceptor) against Thelazia callipaeda in naturally exposed dogs. Vet. Parasitol., 2008, 154(3-4), 351-353.
83. Rinaldi, L.; Calabria, G.; Carbone, S.; Carrella, A.; Cringoli, G. Crenosoma vulpis in dog: first case report in Italy and use of the FLOTAC technique for copromicroscopic diagnosis. Parasitol. Res., 2007, 101(6), 1681-1684.
84. Bowman, D.D.; Ulrich, M.; Gregory, D.E.; Neumann, N.R.; Legg, W.; Stansfield, D. Treatment of Baylisascaris procyonis infections in dogs with milbemycin oxime. Vet. Parasitol., 2005, 129(3-4), 285-290.
85. Overgaauw, P.; Dijk, E.v. Autochthonous case of Dirofilaria repens in a dog in the Netherlands. Vet. Rec., 2009, 164(5), 158.
86. Rossi, L.; Rigano, C.; Tomio, E.; Frassetto, D.; Ferroglio, E. Use of sustained-release moxidectin to prevent eyeworm (Thelazia callipaeda) infection in dogs. Vet. Rec., 2007, 161(24), 820-821.
87. Bianciardi, P.; Otranto, D. Treatment of dog thelaziosis caused by Thelazia callipaeda (Spirurida, Thelaziidae) using a topical formulation of imidacloprid 10% and moxidectin 2.5%. Vet. Parasitol., 2005, 129(1-2), 89-93.
88. Conboy, G.; Hare, J.; Charles, S.; Settje, T.; Heine, J. Efficacy of a single topical application of Advantage Multi®. (=Advocate®.) topical solution (10% imidocloprid+2.5% moxidectin) in the treatment of dogs experimentally infected with Crenosoma vulpis. Parasitol. Res., 2009, 105(Suppl. 1), 49-54.
89. Fok, E.; Jacso, O.; Szebeni, Z.; Gyorffy, A.; Sukosd, L.; Lukacs, Z.; Schaper, R. Elimination of Dirofilaria (syn. Nochtiella) repens microfilariae in dogs with monthly treatments of moxidectin 2.5%/imidacloprid 10% (Advocate®., Bayer) spot-on. Parasitol. Res., 2010, 106(5), 1141-1149.
90. Fisher, M.; Beck, W.; Hutchinson, M.J. Efficacy and safety of selamectin (Stronghold®/Revolution™) used off-label in exotic pets. Int. J. Appl. Res. Vet. Med., 2007, 5(3), 87-96.
91. Mehlhorn, H.; Schmahl, G.; Mevissen, I. Efficacy of a combination of imidacloprid and moxidectin against parasites of reptiles and rodents: case reports. Parasitol. Res., 2005, 97 (Suppl. 1), S97-101.
92. Payne, P.A.; Ridley, R.K. Strategic use of ivermectin during pregnancy to control Toxocara canis in greyhound puppies. Vet. Parasitol., 1999, 85(4), 305-312.
93. Payne-Johnson, M.; Maitland, T.P.; Sherington, J.; Shanks, D.J.; Clements, P.J.; Murphy, M.G.; McLoughlin, A.; Jernigan, A.D.; Rowan, T.G. Efficacy of selamectin administered topically to pregnant and lactating female dogs in the treatment and prevention of adult roundworm (Toxocara canis) infections and flea (Ctenocephalides felis felis) infestations in the dams and their pups. Vet. Parasitol., 2000, 91(3-4), 347-358.
94. Kraemer, F.; Hammerstein, R.; Stoye, M.; Epe, C. Investigations into the prevention of prenatal and lactogenic Toxocara canis infections in puppies by application of moxidectin to the pregnant dog. J. Vet. Med. Series B, 2006, 53(5), 218-223.
95. Kraemer, F.; Epe, C.; Mencke, N. Investigations into the prevention of neonatal Ancylostoma caninum infections in puppies by application of imidacloprid 10% Plus moxidectin 2.5% topical solution to the pregnant dog. Zoonosis Publ. Hlth., 2009, 56(1), 34-40.
96. Lasota, J.A.; Dybas, R.A. Avermectins, a novel class of compounds: implications for use in arthropod pest control. Annu. Rev. Entomol., 1991, 36, 91-117.
97. Zakson-Aiken, M.; Gregory, L.M.; Meinke, P.T.; Shoop, W.L. Systemic activity of the avermectins against the cat flea (Siphonaptera: Pulicidae). J. Med. Entomol., 2001, 38(4), 576-580.
98. Jagannath, M.S.; Yathiraj, S. Clinical evaluation of doramectin in the treatment of ectoparasites of canines. Indian Vet. J., 1999, 76(4), 333-334.
99. Banks, B.J.; Bishop, B.F.; Evans, N.A.; Gibson, S.P.; Goudie, A.C.; Gration, K.A.; Pacey, M.S.; Perry, D.A.; Witty, M.J. Avermectins and flea control: structure-activity relationships and the selection of selamectin for development as an endectocide for companion animals. Bioorg. Med. Chem., 2000, 8(8), 2017-2025.
100. McTier, T.L.; Jernigan, A.D.; Rowan, T.G.; Holbert, M.S.; Smothers, C.D.; Bishop, B.F.; Evans, N.A.; Gration, K.A.; Giles, C.J. Dose selection of selamectin for efficacy against adult fleas (Ctenocephalides felis felis) on dogs and cats. Vet. Parasitol., 2000, 91(3-4), 177-185.
101. Bishop, B.F.; Bruce, C.I.; Evans, N.A.; Goudie, A.C.; Gration, K.A.; Gibson, S.P.; Pacey, M.S.; Perry, D.A.; Walshe, N.D.; Witty, M.J. Selamectin: a novel broad-spectrum endectocide for dogs and cats. Vet. Parasitol., 2000, 91(3-4), 163-176.
102. McTier, T.L.; Jones, R.L.; Holbert, M.S.; Murphy, M.G.; Watson, P.; Sun, F.; Smith, D.G.; Rowan, T.G.; Jernigan, A.D. Efficacy of selamectin against adult flea infestations (Ctenocephalides felis felis and Ctenocephalides canis) on dogs and cats. Vet. Parasitol., 2000, 91(3-4), 187-199.
103. McTier, T.L.; Shanks, D.J.; Jernigan, A.D.; Rowan, T.G.; Jones, R.L.; Murphy, M.G.; Wang, C.; Smith, D.G.; Holbert, M.S.; Blagburn, B.L. Evaluation of the effects of selamectin against adult and immature stages of fleas (Ctenocephalides felis felis) on dogs and cats. Vet. Parasitol., 2000, 91(3-4), 201-212.
104. Shanks, D.J.; Rowan, T.G.; Jones, R.L.; Watson, P.; Murphy, M.G.; Smith, D.G.; Jernigan, A.D. Efficacy of selamectin in the treatment and prevention of flea (Ctenocephalides felis felis) infestations on dogs and cats housed in simulated home environments. Vet. Parasitol., 2000, 91(3-4), 213-222.
105. Benchaoui, H.A.; Clemence, R.G.; Clements, P.J.; Jones, R.L.; Watson, P.; Shanks, D.J.; Smith, D.G.; Sture, G.H.; Jernigan, A.D.; Rowan, T.G. Efficacy and safety of selamectin against fleas on dogs and cats presented as veterinary patients in Europe. Vet. Parasitol., 2000, 91(3-4), 223-232.
106. Boy, M.G.; Six, R.H.; Thomas, C.A.; Novotny, M.J.; Smothers, C.D.; Rowan, T.G.; Jernigan, A.D. Efficacy and safety of selamectin against fleas and heartworms in dogs and cats presented as veterinary patients in North America. Vet. Parasitol., 2000, 91(3-4), 233-250.
107. Scheidt, V.J. Flea allergy dermatitis. Vet. Clin. North Am. Small Anim. Pract., 1988, 18(5), 1023-1042.
108. Dickin, S.K.; McTier, T.L.; Murphy, M.G.; Bond, R.; Mason, I.S.; Payne-Johnson, M.; Smith, D.G.; Evans, N.A.; Jernigan, A.D.; Rowan, T.G. Efficacy of selamectin in the treatment and control of clinical signs of flea allergy dermatitis in dogs and cats experimentally infested with fleas. J. Am. Vet. Med. Assoc., 2003, 223(5), 639-644.
109. Losson, B.; Lonneux, J.F. Field efficacy of moxidectin 0.5% pouron against Chorioptes bovis, Damalinia bovis, Linognathus vituli and Psoroptes ovis in naturally infected cattle. Vet. Parasitol., 1996, 63(1-2), 119-130.
110. Strycharz, J.P.; Yoon, K.S.; Clark, J.M. A new ivermectin formulation topically kills permethrin-resistant human head lice (Anoplura: Pediculidae). J. Med. Entomol., 2008, 45(1), 75-81.
111. Glaziou, P.; Nyguyen, L.N.; Moulia-Pelat, J.P.; Cartel, J.L.; Martin, P.M. Efficacy of ivermectin for the treatment of head lice (Pediculosis capitis). Trop. Med. Parasitol., 1994, 45(3), 253-254.
112. Foucault, C.; Ranque, S.; Badiaga, S.; Rovery, C.; Raoult, D.; Brouqui, P. Oral ivermectin in the treatment of body lice. J. Infect. Dis., 2006, 193(3), 474-476.
113. Burkhart, C.G.; Burkhart, C.N. Oral ivermectin for Phthirus pubis. J. Am. Acad. Dermatol., 2004, 51(6), 1037; author reply 1037-1038.
114. Shanks, D.J.; Gautier, P.; McTier, T.L.; Evans, N.A.; Pengo, G.; Rowan, T.G. Efficacy of selamectin against biting lice on dogs and cats. Vet. Rec., 2003, 152(8), 234-237.
115. Gunnarsson, L.; Christensson, D.; Palmer, E. Clinical efficacy of selamectin in the treatment of naturally acquired infection of sucking lice (Linognathus setosus) in dogs. J. Am. Anim. Hosp. Assoc., 2005, 41(6), 388-394.
116. Davey, R.B.; Miller, J.A.; George, J.E.; Miller, R.J. Therapeutic and persistent efficacy of a single injection treatment of ivermectin and moxidectin against Boophilus microplus (Acari: Ixodidae) on infested cattle. Exp. Appl. Acarol., 2005, 35(1-2), 117-129.
117. Sibson, G. The effects of moxidectin against natural infestations of the cattle tick (Boophilus microplus). Aust. Vet. J., 1994, 71(11), 381-382.
118. Guglielmone, A.A.; Mangold, A.J.; Munoz Cobenas, M.E.; Scherling, N.; Garcia Posse, F.; Anziani, O.S.; Ioppolo, M. Moxidectin pour-on for control of natural populations of the cattle tick Boophilus microplus (Acarina: Ixodidae). Vet. Parasitol., 2000, 87(2-3), 237-241.
119. Jernigan, A.D.; McTier, T.L.; Chieffo, C.; Thomas, C.A.; Krautmann, M.J.; Hair, J.A.; Young, D.R.; Wang, C.; Rowan, T.G. Efficacy of selamectin against experimentally induced tick (Rhipicephalus sanguineus and Dermacentor variabilis) infestations on dogs. Vet. Parasitol., 2000, 91(3-4), 359-375.
120. Sood, S.K.; Salzman, M.B.; Johnson, B.J.; Happ, C.M.; Feig, K.; Carmody, L.; Rubin, L.G.; Hilton, E.; Piesman, J. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic. J. Infect. Dis., 1997, 175(4), 996-999.
121. Piesman, J.; Mather, T.N.; Sinsky, R.J.; Spielman, A. Duration of tick attachment and Borrelia burgdorferi transmission. J. Clin. Microbiol., 1987, 25(3), 557-558.
122. Hojgaard, A.; Eisen, R.J.; Piesman, J. Transmission dynamics of Borrelia burgdorferi s.s. during the key third day of feeding by nymphal Ixodes scapularis (Acari: Ixodidae). J. Med. Entomol., 2008, 45(4), 732-736.
123. Endris, R.G.; Cooke, D.; Amodie, D.; Sweeney, D.L.; Katz, T.L. Repellency and efficacy of 65% permethrin and selamectin spot-on formulations against Ixodes ricinus ticks on dogs. Vet. Ther., 2002, 3(1), 64-71.
124. Losson, B.; Lonneux, J.F. Field efficacy of injectable moxidectin in cattle naturally infested with Chorioptes bovis and Sarcoptes scabiei. Vet. Parasitol., 1993, 51(1-2), 113-121.
125. Lonneux, J.F.; Losson, B. Field efficacy of injectable and pour-on moxidectin in cattle naturally infested with Psoroptes ovis (Acarina: Psoroptidae). Vet. Parasitol., 1992, 45(1-2), 147-152.
126. Lonneux, J.F.; Nguyen, T.Q.; Losson, B.J. Efficacy of pour-on and injectable formulations of moxidectin and ivermectin in cattle naturally infected with Psoroptes ovis: parasitological, clinical and serological data. Vet. Parasitol., 1997, 69(3-4), 319-330.
127. Yathiraj, S.; Rai, M.T.; Reddy, N.R.J.; Muralidhara, A. Treatment of scabies in a cat with ivermectin: a case report. Indian Vet. J., 1994, 71(6), 596-597.
128. Paul, A.J.; Tranquilli, W.J.; Seward, R.L.; Todd, K.S., Jr.; DiPietro, J.A. Clinical observations in collies given ivermectin orally. Am. J. Vet. Res., 1987, 48(4), 684-685.
129. Tranquilli, W.J.; Paul, A.J.; Seward, R.L. Ivermectin plasma concentrations in collies sensitive to ivermectin-induced toxicosis. Am. J. Vet. Res., 1989, 50(5), 769-770.
130. Fassler, P.E.; Tranquilli, W.J.; Paul, A.J.; Soll, M.D.; DiPietro, J.A.; Todd, K.S. Evaluation of the safety of ivermectin administered in a beef-based formulation to ivermectin-sensitive collies. J. Am. Vet. Med. Assoc., 1991, 199(4), 457-460.
131. Miller, W.H., Jr.; de Jaham, C.; Scott, D.W.; Cayatte, S.M.; Bagladi, M.S.; Buerger, R.G. Treatment of canine scabies with milbemycin oxime. Can. Vet. J., 1996, 37(4), 219-221.
132. Yas-Natan, E.; Shamir, M.; Kleinbart, S.; Aroch, I. Doramectin toxicity in a collie. Vet. Rec., 2003, 153(23), 718-720.
133. Nunn-Brooks, L.; Michael, R.; Ravitz, L.; Lappin, M.R. Efficacy of a single dose of an otic ivermection preparation or selamectin for the treatment of Otodectes cynotis infestation in naturally infected cats. J. Vet. Intern. Med., 2008, 22(3), 788.
134. Page, N.; de Jaham, C.; Paradis, M. Observations on topical ivermectin in the treatment of otoacariosis, cheyletiellosis, and toxocariosis in cats. Can. Vet. J., 2000, 41(10), 773-776.
135. Shanks, D.J.; McTier, T.L.; Behan, S.; Pengo, G.; Genchi, C.; Bowman, D.D.; Holbert, M.S.; Smith, D.G.; Jernigan, A.D.; Rowan, T.G. The efficacy of selamectin in the treatment of naturally acquired infestations of Sarcoptes scabiei on dogs. Vet. Parasitol., 2000, 91(3-4), 269-281.
136. Shanks, D.J.; McTier, T.L.; Rowan, T.G.; Watson, P.; Thomas, C.A.; Bowman, D.D.; Hair, J.A.; Pengo, G.; Genchi, C.; Smothers, C.D.; Smith, D.G.; Jernigan, A.D. The efficacy of selamectin in the treatment of naturally acquired aural infestations of Otodectes cynotis on dogs and cats. Vet. Parasitol., 2000, 91(3-4), 283-290.
137. Farkas, R.; Germann, T.; Szeidemann, Z. Assessment of the ear mite (Otodectes cynotis) infestation and the imidacloprid plus moxidectin combination in the treatment of otoacariosis in a Hungarian cat shelter. Parasitol. Res., 2007, 101(Suppl. 1), S35-S44.
138. Bowman, D.D. Georgi's Parasitology for Veterinarians, Saunders Elsevier: St. Louis, Missouri, 2009.
139. Folz, S.D.; Kratzer, D.D.; Conklin, R.D., Jr.; Nowakowski, L.H.; Kakuk, T.J.; Rector, D.L. Chemotherapeutic treatment of naturally acquired generalized demodicosis. Vet. Parasitol., 1983, 13(1), 85-93.
140. Duclos, D.D.; Jeffers, J.G.; Shanley, K.J. Prognosis for treatment of adult-onset demodicosis in dogs: 34 cases (1979-1990). J. Am. Vet. Med. Assoc., 1994, 204(4), 616-619.
141. Paradis, M.; Laperriere, E. Efficacy of daily ivermectin treatment in a dog with amitraz-resistant generalized demodicosis. Vet. Dermatol., 1992, 3(2), 85-88.
142. Mueller, R.S. Treatment protocols for demodicosis: and evidencebased review. Vet. Dermatol., 2004, 15(2), 75-89.
143. O'Malley, K.S. Oral use of ivermectin in the treatment and prophylaxis of generalized canine demodicosis. Canine Pract., 1994, 19(5), 23-29.
144. Ristic, Z.; Medleau, L.; Paradis, M.; White-Weithers, N.E. Ivermectin for treatment of generalized demodicosis in dogs. J. Am. Vet. Med. Assoc., 1995, 207(10), 1308-1310.
145. Burrows, A.K. Generalised demodicosis in the dog: the unresponsive or recurrent case. Aust. Vet. J., 2000, 78(4), 244-246.
146. Zivicnjak, T. A retrospective evaluation of efficiency in therapy for generalized canine demodicosis. Veterinarski Archiv, 2005, 75(4), 303-310.
147. Kamboj, D.S.; Singh, K.B.; Singh, A.; Mohan, R.; Nauriyal, D.C. Studies on the therapeutic efficacy of amitraz, deltamethrin and ivermectin on canine demodicosis. Indian Vet. J., 1993, 70(1), 61-64.
148. Miller, W.H., Jr.; Scott, D.W.; Wellington, J.R.; Panic, R. Clinical efficacy of milbemycin oxime in the treatment of generalized demodicosis in adult dogs. J. Am. Vet. Med. Assoc., 1993, 203(10), 1426-1429.
149. Miller, W.H., Jr.; Scott, D.W.; Cayatte, S.M.; Buerger, R.G.; Bagladi, M.S. Clinical efficacy of increased dosages of milbemycin oxime for treatment of generalized demodicosis in adult dogs. J. Am. Vet. Med. Assoc., 1995, 207(12), 1581-1584.
150. Heine, J.; Krieger, K.; Dumont, P.; Hellmann, K. Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study. Parasitol. Res., 2005, 97 (Suppl 1), S89-96.
151. Ulutas, B.; Voyvoda, H. Efficacy of doramectin in treatment of a dog with generalized demodicosis not affected by amitraz. Turk. Parazit. Derg., 2000, 24(3), 309-310.
152. Johnstone, I.P. Doramectin as a treatment for canine and feline demodicosis. Aust. Vet. Pract., 2002, 32(3), 98-103.
153. Dimri, U.; Singh, S.K.; Sharma, M.C.; Kumar, P.; Waila, T.; Kumar, S.; Ranjan, R.; Kumar, N. Efficacy of doramectin against canine demodicosis. Indian Vet. J., 2009, 86(11), 1127-1128.
154. Saari, S.A.M.; Juuti, K.H.; Palojarvi, J.H.; Vaisanen, K.M.; Rajaniemi, R.L.; Saijonmaa-Koulumies, L.E. Demodes gatoi-associated contagious pruritic dermatosis in cats-a report from six households in Finland. Acta Vet. Scand., 2009, 51, 40.
155. Fisher, M.A.; Shanks, D.J. A review of the off-label use of selamectin in dogs and cats. Acta Vet. Scand., 2008, 50, 46.
156. Curtis, C.F. Current trends in the treatment of Sarcoptes, Cheyletiella and Otodectes mite infestations in dogs and cats. Vet. Dermatol., 2004, 15(2), 108-114.
157. White, S.; Rosychuck, R.; Fieseler, K. Clinicopathological findings, sensitivity to house dust mites and efficacy of milbemycin oxime treatment of dogs with Cheyletiella sp. infestation. Vet. Dermatol., 2001, 12(1), 13-18.
158. Mueller, R.S.; Bettenay, S.V. Efficacy of selamectin in the treatment of canine cheyletiellosis. Vet. Rec., 2002, 151(25), 773.
159. Chailleux, N.; Paradis, M. Efficacy of selamectin in the treatment of naturally acquired cheyletiellosis in cats. Can. Vet. J., 2002, 43(10), 767-770.
160. Leone, F.; Albanese, F. Efficacy of selemectin spot-on formulation against Neotrombicula autmnalis in eight cats. Vet. Dermatol., 2004, 15(Suppl 1), 49.
161. Neff, M.W.; Robertson, K.R.; Wong, A.K.; Safra, N.; Broman, K.W.; Slatkin, M.; Mealey, K.L.; Pedersen, N.C. Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage. Proc. Natl. Acad. Sci. USA, 2004, 101(32), 11725-11730.
162. Umbenhauer, D.R.; Lankas, G.R.; Pippert, T.R.; Wise, L.D.; Cartwright, M.E.; Hall, S.J.; Beare, C.M. Identification of a Pglycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol. Appl. Pharmacol., 1997, 146(1), 88-94.
163. Lee, V.K.; Tiwary, A.K.; Sharma-Reddy, P.; Lieber, K.A.; Taylor, D.K.; Mook, D.M. Moxidectin toxicity in senescence-accelerated prone and resistant mice. Comp. Med., 2009, 59(3), 227-233.
164. Teare, J.A.; Bush, M. Toxicity and efficacy of ivermectin in chelonians. J. Am. Vet. Med. Assoc., 1983, 183(11), 1195-1197.
165. Lierz, M. Evaluation of the dosage of ivermectin in falcons. Vet. Rec., 2001, 148(19), 596-600.
166. Sajid, M.S.; Iqbal, Z.; Muhammad, G.; Iqbal, M.U. Immunomodulatory effect of various anti-parasitics: a review. Parasitology, 2006, 132(3), 301-313.
167. Herd, R.P.; Sams, R.A.; Ashcraft, S.M. Persistence of ivermectin in plasma and faeces following treatment of cows with ivermectin sustained-release, pour-on or injectable formulations. Int. J. Parasitol., 1996, 26(10), 1087-1093.
168. Gokbulut, C.; Nolan, A.M.; McKellar, Q.A. Plasma pharmacokinetics and faecal excretion of ivermectin, doramectin and moxidectin following oral administration in horses. Equine Vet. J., 2001, 33(5), 494-498.
169. Clark, S.L.; Crowley, A.J.; Schmidt, P.G.; Donoghue, A.R.; Piche, C.A. Long-term delivery of ivermectin by use of poly(D, L-lacticco-glycolic)acid microparticles in dogs. Am. J. Vet. Res., 2004, 65(6), 752-757.
170. Arther, R.G.; Charles, S.; Ciszewski, D.K.; Davis, W.L.; Settje, T.S. Imidacloprid/moxidectin topical solution for the prevention of heartworm disease and the treatment and control of flea and intestinal nematodes of cats. Vet. Parasitol., 2005, 133(2-3), 219-225.
171. Holm-Martin, M.; Atwell, R. Evaluation of a single injection of a sustained-release formulation of moxidectin for prevention of experimental heartworm infection after 12 months in dogs. Am. J. Vet. Res., 2004, 65(11), 1596-1599.
172. Leone, F.; Albanese, F.; Fileccia, I. Feline notoedric mange: a report of 22 cases. Prat. Med. Chirurg. Anim. Compag., 2003, 38(5), 421-427.
173. Ramiro-Ibanez, F.; Winston, J.; O'Donnell, E.; Mansell, J. Ulcerative pododermatitis in a cat associated with Anatrichosoma sp. J. Vet. Diagn. Invest., 2002, 14, 80-83.
174. Pereira, M.D.C. The cat fur mite (Lynxacarus radovskyi) in Brazil. Feline Pract., 1996, 24(5), 24-26.
175. Grandi, G.; Calvi, L.E.; Venco, L.; Paratici, C.; Genchi, C.; Memmi, D.; Kramer, L.H. Aelurostrongylus abstrusus (cat lungworm) infection in five cats from Italy. Vet. Parasitol., 2005, 134(1-2), 177-182.
176. Conrads, A.; Wrieg, H.H.; Beck, W. Tropical rat mites (Ornithonyssus bacoti) in a pet hamster-a case report. Kleintierpraxis, 2006, 51(10), 539-543.
177. Curtis, S.K.; Brooks, D.L. Eradication of ear mites from naturally infested conventional research rabbits using ivermectin. Lab. Anim. Sci., 1990, 40(4), 406-408.
178. Conole, J.; Wilkinson, M.J.; McKellar, Q.A. Some observations on the pharmacological properties of ivermectin during treatment of a mite infestation in mice. Contemp. Top. Lab. Anim. Sci., 2003, 42(4), 42-45.
179. Sueta, T.; Miyoshi, I.; Okamura, T.; Kasai, N. Experimental eradication of pinworms (Syphacia obvelata and Aspiculuris tetraptera) from mice colonies using ivermectin. Exp. Anim., 2002, 51(4), 367-373.
180. Bodri, M.S.; Nolan, T.J.; Skeeba, S.J. Safety of milbemycin (A3-A4 oxime) in chelonians. J. Zoo Wildlife Med., 1993, 245(2), 171-174.
181. Mook, D.M.; Benjamin, K.A. Use of selamectin and moxidectin in the treatment of mouse fur mites. J. Amer. Assoc. Lab. An. Sci., 2008, 47(3), 20-24.
182. Pollicino, P.; Rossi, L.; Rambozzi, L.; Farca, A.M.; Peano, A. Oral administration of moxidectin for treatment of murine acariosis due to Radfordia affinis. Vet. Parasitol., 2008, 151(2-4), 355-357.
183. Pullium, J.K.; Brooks, W.J.; Langley, A.D.; Huerkamp, M.J. A single dose of topical moxidectin as an effective treatment for murine acariasis due to Myocoptes musculinus. Contemp. Top. Lab. Anim. Sci., 2005, 44(1), 26-28.
184. Kim, S.; Lee, J.; Jun, H.; Song, K.; Park, B.; Kim, D. Efficacy of selamectin in the treatment of cheyletiellosis in pet rabbits. Vet. Dermatol., 2008, 19(1), 26-27.
185. Kurtdede, A.; Karaer, Z.; Acar, A.; Guzel, M.; Cingi, C.C.; Ural, K.; Ica, A. Use of selamectin for the treatment of psoroptic and sarcoptic mite infestation in rabbits. Vet. Dermatol., 2007, 18(1), 18-22.
186. Esatgil, M.U.; Gulanber, A.; Aydin, H. Use of topical selamectin for the treatment of Trichosomoides crassicauda infection in laboratory rats. Pol. J. Vet. Sci., 2008, 11(2), 143-145.
187. Bornstein, D.A.; Scola, J.; A., R.; Warren, H.B. Multimodal approach, to treatment for control of fur mites. J. Amer. Assoc. Lab. An. Sci., 2006, 45(4), 29-32.